Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[18F]FGln PET Imaging.

Chao LiShuo HuangJun GuoCheng WangZhichao HuangRuimin HuangLiang LiuSheng LiangHui Wang

Published in: Molecular imaging and biology (2020)

4-[18F]FGln PET can provide a valuable clinical tool in the assessment of metabolic glutamine uptake in MYCN-amplified neuroblastoma. ASCT2-targeted therapy may provide a supplementary method in MYCN-amplified neuroblastoma treatment.

Keyphrases

pet imaging
positron emission tomography
computed tomography
pet ct
combination therapy
replacement therapy
smoking cessation